Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Delaloye

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Virulence|October 26, 2013
Invasive candidiasis as a cause of sepsis in the critically ill patientJulie Delaloye, Thierry Calandra
Current Vascular Pharmacology|March 20, 2013
Host innate immune responses to microbial pathogensJulie Delaloye, Thierry Calandra
Intensive Care Medicine|July 10, 2020
Serum antibody response in critically ill patients with COVID-19Alban Longchamp, Justine Longchamp, Antony Croxatto, et al.
The Journal of Infectious Diseases|November 6, 2012
Macrophage migration inhibitory factor deficiency is associated with impaired killing of gram-negative bacteria by macrophages and increased susceptibility to Klebsiella pneumoniae sepsisThierry Roger, Julie Delaloye, Anne-Laure Chanson, et al.
Revue Medicale Suisse|July 21, 2017
[Toxocariasis, a neglected disease in Switzerland ?]Amélie Duréault, Carlos Perez Valdes, Lalensia Weber, et al.
Plos One|September 27, 2013
Deletion of the vaccinia virus gene A46R, encoding for an inhibitor of TLR signalling, is an effective approach to enhance the immunogenicity in mice of the HIV/AIDS vaccine candidate NYVAC-CBeatriz Perdiguero, Carmen Elena Gómez, Mauro Di Pilato, et al.
Journal of Medical Case Reports|November 19, 2015
Tropheryma whipplei bivalvular endocarditis and polyarthralgia: a case reportJanina Rivas Gruber, Rossella Sarro, Julie Delaloye, et al.
Cytokine|August 18, 2012
Increased macrophage migration inhibitory factor (MIF) plasma levels in acute HIV-1 infectionJulie Delaloye, Irma J A De Bruin, Katharine E A Darling, et al.
BMJ Open|November 21, 2022
Investigating nanomotion-based technology (Resistell AST) for rapid antibiotic susceptibility testing among adult patients admitted to a tertiary-care hospital with Gram-negative bacteraemia: protocol for a prospective, observational, cross-sectional, single-arm studyGiorgia Caruana, Antonios Kritikos, Anthony Vocat, et al.
Plos One|November 3, 2012
Deletion of the viral anti-apoptotic gene F1L in the HIV/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigensBeatriz Perdiguero, Carmen Elena Gómez, Jose Luis Nájera, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Virulence|October 26, 2013
Invasive candidiasis as a cause of sepsis in the critically ill patientJulie Delaloye, Thierry Calandra
Current Vascular Pharmacology|March 20, 2013
Host innate immune responses to microbial pathogensJulie Delaloye, Thierry Calandra
Intensive Care Medicine|July 10, 2020
Serum antibody response in critically ill patients with COVID-19Alban Longchamp, Justine Longchamp, Antony Croxatto, et al.
The Journal of Infectious Diseases|November 6, 2012
Macrophage migration inhibitory factor deficiency is associated with impaired killing of gram-negative bacteria by macrophages and increased susceptibility to Klebsiella pneumoniae sepsisThierry Roger, Julie Delaloye, Anne-Laure Chanson, et al.
Revue Medicale Suisse|July 21, 2017
[Toxocariasis, a neglected disease in Switzerland ?]Amélie Duréault, Carlos Perez Valdes, Lalensia Weber, et al.
Plos One|September 27, 2013
Deletion of the vaccinia virus gene A46R, encoding for an inhibitor of TLR signalling, is an effective approach to enhance the immunogenicity in mice of the HIV/AIDS vaccine candidate NYVAC-CBeatriz Perdiguero, Carmen Elena Gómez, Mauro Di Pilato, et al.
Journal of Medical Case Reports|November 19, 2015
Tropheryma whipplei bivalvular endocarditis and polyarthralgia: a case reportJanina Rivas Gruber, Rossella Sarro, Julie Delaloye, et al.
Cytokine|August 18, 2012
Increased macrophage migration inhibitory factor (MIF) plasma levels in acute HIV-1 infectionJulie Delaloye, Irma J A De Bruin, Katharine E A Darling, et al.
BMJ Open|November 21, 2022
Investigating nanomotion-based technology (Resistell AST) for rapid antibiotic susceptibility testing among adult patients admitted to a tertiary-care hospital with Gram-negative bacteraemia: protocol for a prospective, observational, cross-sectional, single-arm studyGiorgia Caruana, Antonios Kritikos, Anthony Vocat, et al.
Plos One|November 3, 2012
Deletion of the viral anti-apoptotic gene F1L in the HIV/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigensBeatriz Perdiguero, Carmen Elena Gómez, Jose Luis Nájera, et al.
Pageof 3